Angelo Paradiso
Overview
Explore the profile of Angelo Paradiso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
211
Citations
8406
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Angelo Paradiso , Bravaccini S, Pronzato P
Breast Care (Basel)
. 2023 Oct;
18(4):317-319.
PMID: 37900551
No abstract available.
2.
Loizzi V, Cicinelli E, Del Vecchio V, Arezzo F, Deromemaj X, Kardhashi A, et al.
Acta Biomed
. 2022 Aug;
93(4):e2022051.
PMID: 36043985
Background And Aim Of The Work: BRCA1/2 are tumour-suppressor genes involved in DNA homologous recombination and ovarian cancer development. The study evaluated the risk of tumor cancer in women presenting...
3.
Costanzo S, De Summa S, Maurmo L, Digennaro M, Patruno M, Angelo Paradiso
Fam Cancer
. 2022 Jul;
22(1):43-48.
PMID: 35867288
During Covid-19 pandemic most hospitals have restricted in-person delivery of non-essential healthcare services, including genetic testing delivery, to slow the spread of the virus. Our Onco-Genetic Service also faced this...
4.
Oliverio A, Radice P, Colombo M, Angelo Paradiso , Tommasi S, Daniele A, et al.
Front Genet
. 2022 Mar;
13:820878.
PMID: 35356420
The female carriers of pathogenic variants (mutations) face a high lifetime risk of developing breast and/or ovarian cancer. However, the risk may differ depending on various genetic and non-genetic elements,...
5.
Serrati S, Guida M, Di Fonte R, De Summa S, Strippoli S, Iacobazzi R, et al.
Mol Cancer
. 2022 Jan;
21(1):20.
PMID: 35042524
Background: The immunotherapy with immune checkpoints inhibitors (ICI) has changed the life expectancy in metastatic melanoma (MM) patients. Nevertheless, several patients do not respond hence, the identification and validation of...
6.
Angelo Paradiso , Codacci-Pisanelli G, Munzone E, Rugo H, Heudel P
Breast Care (Basel)
. 2021 Nov;
16(5):552-557.
PMID: 34720818
No abstract available.
7.
Patruno M, De Summa S, Resta N, Caputo M, Costanzo S, Digennaro M, et al.
Cancers (Basel)
. 2021 Sep;
13(18).
PMID: 34572941
BRCA1/2-associated hereditary breast and ovarian cancer is the most common form of hereditary breast and ovarian cancer and occurs in all ethnicities and racial populations. Different BRCA1/BRCA2 pathogenic variants (PVs)...
8.
Desantis V, Solimando A, Saltarella I, Sacco A, Giustini V, Bento M, et al.
Cancers (Basel)
. 2021 Aug;
13(15).
PMID: 34359551
Multiple myeloma (MM) is a hematological malignancy characterised by proliferation of clonal plasma cells (PCs) within the bone marrow (BM). Myelomagenesis is a multi-step process which goes from an asymptomatic...
9.
Marciniak W, Matousek T, Domchek S, Angelo Paradiso , Patruno M, Irmejs A, et al.
Cancers (Basel)
. 2021 Jul;
13(13).
PMID: 34283078
An important group of breast cancers is those associated with inherited susceptibility. In women, several predisposing mutations in genes involved in DNA repair have been discovered. Women with a germline...
10.
Divella R, De Palma G, Tufaro A, Pelagio G, Gadaleta-Caldarola G, Bringiotti R, et al.
Anticancer Res
. 2021 Jun;
41(6):2759-2772.
PMID: 34083266
The intestinal microbiota, which has gained a foothold in the field of research, represents a significant factor for human health because of its ability to form relationships with the organism...